Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

dentalcorp Holdings Ltd T.DNTL

Alternate Symbol(s):  DNTCF

dentalcorp Holdings Ltd. is a Canada-based consumer healthcare services company, which is a provider of dental services in Canada. The principal activity of the Company, through its subsidiaries, is to acquire dental practices and provide health care services in Canada. The Company owns and operates a network of 535 dental practices. Its nationwide network is comprised of 1,850 dentists, over 2,400 hygienists, and over 5,400 auxiliary dental health professionals. The Company’s subsidiaries include Dentalcorp Health Services Ltd., DCC Health Services (Quebec) Inc., 1348856 B.C. Ltd. and Dentalcorp Holdings (US) Ltd.


TSX:DNTL - Post by User

Post by retiredcfon Mar 02, 2022 8:25am
103 Views
Post# 34474122

TD Notes

TD Notes

Q4/21 Previews & Estimate/Target Revisions TD Investment Conclusion

We are providing company specific outlooks for Q4/21 results and updating estimates for several of our special situations names under coverage (ITP, NFI, BDGI, and DNTL). We have not made any rating changes in this note; our BUY recommendations on Intertape Polymer Group and dentalcorp remain unchanged, as do our HOLD recommendations for each of NFI Group and Badger Infrastructure Solutions.

Changes to our Q4/21 and longer-term estimates largely reflect company and industry specific factors based on insights gained from recently reported Q4/21 results and 2022 outlooks by competitors, suppliers, and end-customers to our companies under coverage. Although unique to each company, we have noted a larger-than-anticipated impact from Omicron in terms of labour availability and cost impacts (overtime, sick pay, and broader scheduling inefficiencies) across the imperfect peers. Additionally, the impacts of supply chain challenges appear to be more severe and protracted into 2022 than we had initially assumed in our forecasting. We have also adjusted our currency assumptions.


<< Previous
Bullboard Posts
Next >>